Angiodynamics (ANGO) Total Current Liabilities (2011 - 2026)

Angiodynamics (ANGO) has reported Total Current Liabilities for 16 consecutive years, with $74.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Current Liabilities fell 1.94% year-over-year to $74.7 million; the trailing twelve-month figure through May 2026 stood at $74.7 million (down 1.94% YoY), and the FY2026 full-year result was $74.7 million, down 1.94% from the prior year.
• Total Current Liabilities advanced to $74.7 million in Q2 2026 per ANGO's latest filing, from $66.1 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $91.2 million in Q2 2024 and bottomed at $49.4 million in Q1 2022.
• Historically, Total Current Liabilities has averaged $73.9 million across 5 years, with a median of $74.5 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Total Current Liabilities surged 41.05% in 2023, then decreased 18.77% in 2025.
• Over 5 years, Total Current Liabilities stood at $73.6 million in 2022, then grew by 6.08% to $78.0 million in 2023, then increased by 13.53% to $88.6 million in 2024, then slipped by 18.77% to $72.0 million in 2025, then gained by 3.83% to $74.7 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $74.7 million, $66.1 million, and $72.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.